Direkt zum Inhalt
Merck

Diagnosis and management of oral leishmaniasis--case series and literature review.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons (2014-02-01)
Chen Nadler, Claes D Enk, Gilead T Leon, Yuval Samuni, Alexander Maly, Rakefet Czerninski
ZUSAMMENFASSUNG

The worldwide prevalence of leishmaniasis is increasing because of ecologic changes and increased medical profession awareness. Furthermore, solitary cases have been recently reported in Western countries. The authors describe the epidemiology, mode of transmission, and diagnosis of leishmaniasis and present 4 oral cases treated with systemic, localized, or combined therapy. The authors suggest that clinicians should maintain a high index of suspicion for atypical, resistant, oral and perioral lesions in individuals with a history of traveling in certain geographic regions. After diagnosis, treatment should be determined jointly by experts from the fields of oral and maxillofacial surgery, oral medicine, and dermatology based on leishmaniasis species and clinical presentation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Amphotericin B -Lösung, 250 μg/mL in deionized water, 0.1 μm filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Amphotericin B, gelöst, powder, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
Amphotericin B aus Streptomyces sp., ~80% (HPLC), powder
Sigma-Aldrich
Amphotericin B aus Streptomyces sp., BioReagent, suitable for cell culture, ~80% (HPLC)
Amphotericin B, European Pharmacopoeia (EP) Reference Standard
Amphotericin B für mikrobiologischen Assay, European Pharmacopoeia (EP) Reference Standard
Amphotericin B für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard